Epirubicin Intravenous, Injection and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Epirubicin Intravenous, Injection and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: epirubicin
Brand name: Ellence, Pharmorubicin Pfs, Pharmorubicin RDF
Synonyms: Epirubicin, EPIrubicin
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epirubicin Intravenous, Injection-Insulin glargine, recombinant Subcutaneous
- Epirubicin Intravenous, Injection-Insulin glulisine
- Epirubicin Intravenous, Injection-Insulin Glulisine (Cartridges and Pens)
- Epirubicin Intravenous, Injection-Insulin Glulisine (Vials)
- Epirubicin Intravenous, Injection-Insulin glulisine Subcutaneous
- Epirubicin Intravenous, Injection-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-EPIsnap
- Insulin glargine and lixisenatide Subcutaneous-Epitol
- Insulin glargine and lixisenatide Subcutaneous-Epivir
- Insulin glargine and lixisenatide Subcutaneous-Epivir (Lamivudine Oral Solution)
- Insulin glargine and lixisenatide Subcutaneous-Epivir (Lamivudine Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Epivir A/F